These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 8137259)
21. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance. Modlin CS; Todd GT; Cohen TD; Fairchild RL Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330 [TBL] [Abstract][Full Text] [Related]
23. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen. Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573 [TBL] [Abstract][Full Text] [Related]
24. Persistence of V beta 6+ T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition. Chies JA; Marodon G; Joret AM; Regnault A; Lembezat MP; Rocha B; Freitas AA J Immunol; 1995 Nov; 155(9):4171-8. PubMed ID: 7594572 [TBL] [Abstract][Full Text] [Related]
25. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen. Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553 [TBL] [Abstract][Full Text] [Related]
26. Dramatic hyperplasia of mtv-2+ lymph node grafts in mtv-2- recipients and selective stimulation of V beta 14+ T cells in recipients' lymph nodes in the DDD mouse. Matsuzawa A; Nakano H; Sakamoto S; Yoshimoto T; Nariuchi H J Immunol; 1995 Feb; 154(4):1644-52. PubMed ID: 7836749 [TBL] [Abstract][Full Text] [Related]
27. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function. Tsai SJ; Loeffler DA; Heppner GH Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224 [TBL] [Abstract][Full Text] [Related]
28. In vivo T cell response to viral superantigen. Selective migration rather than proliferation. Le Bon A; Lucas B; Vasseur F; Penit C; Papiernik M J Immunol; 1996 Jun; 156(12):4602-8. PubMed ID: 8648102 [TBL] [Abstract][Full Text] [Related]
30. CD4 expression is important but not essential for infection with exogenous mouse mammary tumor virus. Ando Y; Wajjwalku W; Kishihara K; Arai T; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y Immunobiology; 1996 Aug; 195(3):376-84. PubMed ID: 8877410 [TBL] [Abstract][Full Text] [Related]
31. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus. Tucek CL; Desaymard C; Papiernik M J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538 [TBL] [Abstract][Full Text] [Related]
32. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651 [TBL] [Abstract][Full Text] [Related]
33. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages. Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568 [TBL] [Abstract][Full Text] [Related]
34. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse. Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042 [TBL] [Abstract][Full Text] [Related]
35. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion. Wei WZ; Fulton A; Winkelhake J; Heppner G Cancer Res; 1989 May; 49(10):2709-15. PubMed ID: 2785436 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells. Foo-Phillips M; Kozak CA; Principato MA; Abe R J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236 [TBL] [Abstract][Full Text] [Related]
37. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Kapoun AM; Shackleford GM Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106 [TBL] [Abstract][Full Text] [Related]
38. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics. Pullen AM; Bogatzki LY J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038 [TBL] [Abstract][Full Text] [Related]
39. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion. Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876 [TBL] [Abstract][Full Text] [Related]